Skip to main content

Table 3 Cardiac function and mass

From: Changes of myocardial lipidomics profiling in a rat model of diabetic cardiomyopathy using UPLC/Q-TOF/MS analysis

Group LVSP (mmHg) dp/dt max (mmHg/s) LVEDP (mmHg) dp/dt min (mmHg/s) Whole heart weight (g) Body weight (g) Whole heart weight/body weight (%) Water consumption (mL/24 h)
Control 112 ± 17 5822 ± 1740 −0.08 ± 1.30 −7680 ± 1866 1.389 ± 0.185 574 ± 35 0.24 ± 0.026 33 ± 9
DCM model 88 ± 14* 3637 ± 733* 2.78 ± 2.32* −4269 ± 1076* 1.269 ± 0.105 426 ± 56** 0.30 ± 0.020** 206 ± 50***
  1. Values given are mean ± SEM, with n = 12
  2. DCM, diabetic cardiomyopathy; LVSP, left ventricular systolic pressure; dp/dt max, the maximal uprising velocity of left ventricular pressure; LVEDP, left ventricular end diastolic pressure; dp/dt min, the maximal decreasing velocity of left ventricular pressure
  3. * P < 0.05, ** P < 0.01, *** P < 0.001 versus control group